ABSTRACT
ABSTRACT Background: COVID-19 is a new disease and the most common complication is pneumonia. The Radiological Society of North America (RSNA) proposed an expert consensus for imaging classification for COVID-19 pneumonia. Objective: To evaluate sensitivity, specificity, accuracy, and reproducibility of chest CT standards in the beginning of the Brazilian COVID-19 outbreak. Methods: Cross-sectional study performed from March 1st to April 14th, 2020. Patients with suspected COVID-19 pneumonia submitted to RT-PCR test and chest computed tomography (CT) were included. Two thoracic radiologists blinded for RT-PCR and clinical and laboratory results classified every patient scan according to the RSNA expert consensus. A third thoracic radiologist also evaluated in case of discordance, and consensus was reached among the three radiologists. A typical appearance was considered a positive chest CT for COVID-19 pneumonia. Sensitivity, specificity, positive and negative predictive values were calculated. Cohen's kappa coefficient was used to evaluate intra- and inter-rater agreements. Results: A total of 159 patients were included (mean age 57.9 ± 18.0 years; 88 [55.3%] males): 86 (54.1%) COVID-19 and 73 (45.9%) non-COVID-19 patients. Eighty (50.3%) patients had a positive CT for COVID-19 pneumonia. Sensitivity and specificity of typical appearance were 88.3% (95%CI, 79.9-93.5) and 94.5% (95%CI, 86.7-97.8), respectively. Intra- and inter-rater agreement were assessed (Cohen's kappa = 0.924, P= 0.06; Cohen's kappa=0.772, P= 0.05, respectively). Conclusion: Chest CT categorical classification of COVID-19 findings is reproducible and demonstrates high level of agreement with clinical and RT-PCR diagnosis of COVID-19. In RT-PCR scarcity scenarios or in equivocal cases, it may be useful for attending physicians in the evaluation of suspected COVID-19 pneumonia patients attended at the emergency unit.
Subject(s)
Adult , Aged , Humans , Male , Middle Aged , Pneumonia, Viral , Coronavirus Infections , Betacoronavirus , COVID-19 , Pneumonia, Viral/epidemiology , Reference Standards , Brazil , Tomography, X-Ray Computed , Cross-Sectional Studies , Reproducibility of Results , Coronavirus Infections/epidemiology , Pandemics , SARS-CoV-2ABSTRACT
ABSTRACT A retrospective cohort study, were evaluated: polymyxin B plus aminoglycosides or polymyxin B plus other antibiotics. Any degree of acute kidney injury occurred in 26 (86.6%) patients. The median time to acute kidney injury was 6.0 (95% CI 3-14) days in the polymyxin-aminoglycoside containing regimen group, against 27.0 (95% CI 6-42) days in the polymyxin with other antimicrobial combinations group (p = 0.03). Polymyxin B with aminoglycosides group progressed faster to any degree of renal dysfunction.
Subject(s)
Humans , Male , Female , Polymyxin B/therapeutic use , Enterobacteriaceae Infections/drug therapy , Kidney/drug effects , Mediastinitis/microbiology , Mediastinitis/drug therapy , Anti-Bacterial Agents/therapeutic use , Microbial Sensitivity Tests , Carbapenems/pharmacology , Retrospective Studies , Treatment Outcome , Statistics, Nonparametric , Risk Assessment , beta-Lactam Resistance/drug effects , Enterobacteriaceae Infections/mortality , Kaplan-Meier Estimate , Acute Kidney Injury/chemically induced , Aminoglycosides/therapeutic use , Mediastinitis/mortalitySubject(s)
Adult , Humans , Male , Anti-Bacterial Agents/pharmacology , beta-Lactam Resistance , Carbapenems/pharmacology , Klebsiella pneumoniae/enzymology , beta-Lactamases/biosynthesis , Brazil , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Microbial Sensitivity Tests , PhenotypeABSTRACT
The molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae (KPC) has been largely investigated, but limited clinical information is available. A case-control study was performed to evaluate the risk factors for KPC bacteremia in hospitalized patients. Cases were patients with KPC bacteremia and controls were patients with non-KPC bacteremia. A total of 85 patients were included, 18 (21.2%) were KPC, and 67 (78.8%) were non-KPC (40 [59.7%] of them were extended-spectrum beta-lactamase producers). All KPC isolates were type 2 producers. These isolates belong to five distinct clones. Multivariate analysis showed that age (odds ratio [OR], 1.06; 95% confidence interval [CI], 1.02 - 1.11; p = 0.004), presence of mechanical ventilation (OR, 11.1; 95% CI, 1.92 - 63.3; p = 0.007) and fluoroquinolone exposure during hospitalization (OR, 28.9; 95% CI, 1.85 - 454.6; p = 0.02) were independent risk factors for KPC in patients with K. pneumoniae bacteremia. Factors associated with severity of illness, such as age and mechanical ventilation, seem to be the main risks factors for KPC. Fluoroquinolones use might be a risk factor for KPC bacteremia. Further investigations on risk factors for KPC are warranted.
Subject(s)
Female , Humans , Male , Middle Aged , Bacteremia/microbiology , Bacterial Proteins/metabolism , Cross Infection/microbiology , Klebsiella Infections/microbiology , Klebsiella pneumoniae/enzymology , beta-Lactamases/metabolism , Bacteremia/diagnosis , Cross Infection/diagnosis , Epidemiologic Methods , Klebsiella Infections/diagnosis , Klebsiella Infections/epidemiologyABSTRACT
A febre de origem indeterminada (FOI) é uma entidade nosológica frequentemente encontrada na prática clínica diária, mas pouco lembrada durante a graduação em medicina. O objetivo desse trabalho é fazer uma revisão sobre o tema para que frente a um caso sugestivo de FOI, esse diagnóstico seja identificado, facilitando sua abordagem diagnóstica e terapêutica.